BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home » Topics » Regulatory » Patents

Patents
Patents RSS Feed RSS

Cancer

Chinese researchers discover new SOS1 inhibitors

Feb. 20, 2023
Shanghai Aryl Pharmtech Co. Ltd. and Zhejiang Hisun Pharmaceutical Co. Ltd. have described pyrimidocyclic derivatives acting as son of sevenless homolog 1 (SOS1) inhibitors reported to be useful for the treatment of cancer, cardiofaciocutaneous and Noonan syndrome.
Read More
Neurology/Psychiatric

Theranocure presents MRI contrast agents for use in Alzheimer's and Parkinson's diseases

Feb. 20, 2023
Theranocure Co. Ltd. has divulged gadolinium complexes targeting β-amyloid protein acting as magnetic resonance imaging (MRI) contrast agents reported to be useful for the diagnosis of Alzheimer's disease and the treatment of Parkinson's and Alzheimer's disease.
Read More
Lungs and bronchi
Respiratory

Rijksuniversiteit Groningen describes new HDAC inhibitors

Feb. 20, 2023
Rijksuniversiteit Groningen has identified histone deacetylase (HDAC) inhibitors reported to be useful for the treatment of asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, small cell and non-small-cell lung cancer (NSCLC).
Read More
Escherichia coli bacteria
Infection

French researchers divulge new efflux pump inhibitors for gram-negative bacterial infections

Feb. 20, 2023
Centre Hospitalier Regional Universitaire de Lille, Centre National de la Recherche Scientifique, INSERM and Institut Pasteur de Lille have synthesized efflux pump inhibitors reported to be useful for the treatment of gram-negative bacterial infections.
Read More
Infection

Novartis patents new neuraminidase inhibitors for influenza

Feb. 20, 2023
Novartis AG has disclosed neuraminidase inhibitors acting as viral replication inhibitors reported to be useful for the treatment of influenza.
Read More

BioWorld MedTech Patent Highlights: Week 6

From Current Patent Gazette
Feb. 17, 2023
BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.
Read More
Cancer

Medshine Discovery identifies new GSPT1-targeting PROTACs

Feb. 17, 2023
Medshine Discovery Inc. has presented heteroaryl-3-piperidinediones acting as proteolysis targeting chimera (PROTAC) compounds comprising cereblon (CRBN) E3 ubiquitin ligase-binding moiety covalently linked to eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)-targeting moiety through linker.
Read More
Infection

Selmod divulges new antifungal compounds

Feb. 17, 2023
Selmod GmbH has identified compounds reported to be useful for the treatment of fungal infections.
Read More
Cancer

Carna Biosciences discovers new STING antagonists

Feb. 17, 2023
Carna Biosciences Inc. has synthesized 1,2-diaminobenzimidazole derivatives acting as stimulator of interferon genes protein (STING) antagonists reported to be useful for the treatment of cancer, viral infection, neurodegeneration and autoimmune, inflammatory, metabolic, eye and cardiovascular disorders, among others.
Read More
Neurology/Psychiatric

Astellas Pharma and Kotobuki Pharmaceutical patent new NLRP3 inflammasome inhibitors

Feb. 17, 2023
Astellas Pharma Inc. and Kotobuki Pharmaceutical Co. Ltd. have divulged annulated pyridazines...
Read More
Previous 1 2 … 409 410 411 412 413 414 415 416 417 … 3798 3799 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 7, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing